| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.604 | 0.002 | 0.604 | Succinate dehydrogenase inhibitor | 0.223 0.033 CID_16042756 | ||
| 0.43 | 0.004 | 0.43 | Prostaglandin E2 antagonist | 0.072 0.023 CID_16042756 | ||
| 0.453 | 0.05 | 0.453 | 5 Hydroxytryptamine release inhibitor | 0.282 0.186 CID_16042756 | ||
| 0.446 | 0.069 | 0.736 | Cyclophilin D inhibitor | 0.736 0.011 CID_16042756 | CID_16042756 | |
| 0.373 | 0.004 | 0.373 | Prostaglandin antagonist | |||
| 0.397 | 0.067 | 0.397 | Antiobesity | 0.348 0.088 CID_16042756 | ||
| 0.314 | 0.005 | 0.314 | Potassium channel (Ca-activated) activator | 0.11 0.048 CID_16042756 | ||
| 0.308 | 0.01 | 0.308 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.298 | 0.005 | 0.298 | Uric acid excretion stimulant | 0.223 0.01 CID_16042756 | ||
| 0.365 | 0.078 | 0.365 | GABA C receptor rho-3 antagonist | |||
| 0.295 | 0.011 | 0.352 | Hexokinase inhibitor | 0.352 0.006 CID_16042756 | CID_16042756 | |
| 0.255 | 0.003 | 0.255 | Urate transporter 1 inhibitor | |||
| 0.27 | 0.029 | 0.27 | Mcl-1 antagonist | |||
| 0.237 | 0.004 | 0.237 | Prostaglandin EP1 antagonist | |||
| 0.342 | 0.113 | 0.342 | Analgesic | |||
| 0.231 | 0.007 | 0.231 | Creatine kinase inhibitor | |||
| 0.237 | 0.019 | 0.307 | Cell wall synthesis inhibitor | 0.307 0.009 CID_16042756 | CID_16042756 | |
| 0.222 | 0.005 | 0.222 | Potassium channel large-conductance Ca-activated activator | 0.1 0.024 CID_16042756 | ||
| 0.22 | 0.017 | 0.22 | Farnesoid X receptor antagonist | 0.135 0.074 CID_16042756 | ||
| 0.197 | 0.004 | 0.197 | Nicotinic acid receptor 2 agonist | |||
| 0.21 | 0.03 | 0.21 | M17 leucyl aminopeptidase inhibitor | |||
| 0.183 | 0.004 | 0.183 | Guanylate cyclase stimulant | 0.045 0.027 CID_16042756 | ||
| 0.181 | 0.004 | 0.181 | Prostaglandin F2 alpha antagonist | 0.11 0.009 CID_16042756 | ||
| 0.253 | 0.078 | 0.253 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.2 | 0.034 | 0.2 | NADPH oxidase inhibitor | 0.16 0.049 CID_16042756 | ||
| 0.186 | 0.028 | 0.186 | Cystathionine beta-synthase inhibitor | 0.106 0.071 CID_16042756 | ||
| 0.174 | 0.02 | 0.174 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.147 0.028 CID_16042756 | ||
| 0.155 | 0.01 | 0.155 | Cannabinoid CB1 receptor agonist | |||
| 0.208 | 0.065 | 0.336 | Non-steroidal antiinflammatory agent | 0.336 0.021 CID_16042756 | CID_16042756 | |
| 0.233 | 0.099 | 0.233 | Transcription factor STAT inhibitor | |||
| 0.254 | 0.122 | 0.437 | Cholesterol antagonist | 0.437 0.043 CID_16042756 | CID_16042756 | |
| 0.186 | 0.06 | 0.186 | Antipruritic | |||
| 0.129 | 0.003 | 0.129 | Kynurenine 3 monooxygenase inhibitor | 0.024 0.022 CID_16042756 | ||
| 0.134 | 0.012 | 0.134 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.153 | 0.035 | 0.153 | Ca2+-transporting ATPase inhibitor | 0.145 0.056 CID_16042756 | ||
| 0.171 | 0.06 | 0.171 | Diuretic | 0.139 0.086 CID_16042756 | ||
| 0.146 | 0.039 | 0.146 | Ferrochelatase inhibitor | |||
| 0.228 | 0.121 | 0.243 | Hypoxia-inducible factor 1 alpha inhibitor | 0.243 0.107 CID_16042756 | CID_16042756 | |
| 0.113 | 0.011 | 0.113 | NMDA receptor glycine site agonist | |||
| 0.109 | 0.008 | 0.109 | Elastase inhibitor | 0.051 0.041 CID_16042756 | ||
| 0.12 | 0.02 | 0.12 | Bile acid receptor antagonist | |||
| 0.17 | 0.07 | 0.241 | ATPase inhibitor | 0.241 0.016 CID_16042756 | CID_16042756 | |
| 0.122 | 0.028 | 0.122 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.097 | 0.005 | 0.097 | CC chemokine 4 receptor antagonist | |||
| 0.108 | 0.017 | 0.108 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.107 | 0.017 | 0.107 | NMDA receptor agonist | |||
| 0.102 | 0.015 | 0.102 | GABA B receptor agonist | |||
| 0.095 | 0.008 | 0.095 | Nicotinic acid receptor 1 agonist | |||
| 0.108 | 0.023 | 0.108 | Cannabinoid receptor agonist | |||
| 0.3 | 0.216 | 0.732 | Antiinflammatory | 0.732 0.025 CID_16042756 | CID_16042756 | |
| 0.087 | 0.005 | 0.087 | Pregnane X receptor antagonist | |||
| 0.164 | 0.087 | 0.164 | Amyloid beta precursor protein antagonist | |||
| 0.083 | 0.008 | 0.083 | Estrogen-related receptor alpha antagonist | 0.029 0.028 CID_16042756 | ||
| 0.118 | 0.046 | 0.18 | Toll-Like receptor 4 antagonist | 0.18 0.01 CID_16042756 | CID_16042756 | |
| 0.109 | 0.037 | 0.109 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.099 | 0.029 | 0.099 | Cannabinoid receptor antagonist | |||
| 0.086 | 0.017 | 0.086 | Thromboxane antagonist | |||
| 0.153 | 0.085 | 0.153 | Arachidonic acid antagonist | |||
| 0.292 | 0.224 | 0.292 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.133 | 0.067 | 0.133 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.075 | 0.009 | 0.075 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.091 | 0.026 | 0.091 | Purinergic P2 antagonist | |||
| 0.072 | 0.007 | 0.072 | Prostaglandin EP3 antagonist | |||
| 0.11 | 0.046 | 0.11 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.135 | 0.071 | 0.135 | Alkaline phosphatase inhibitor | |||
| 0.077 | 0.014 | 0.077 | Purinergic P2X antagonist | |||
| 0.098 | 0.037 | 0.098 | Chymotrypsin inhibitor | |||
| 0.069 | 0.009 | 0.069 | Nicotinic acid receptor agonist | |||
| 0.063 | 0.004 | 0.063 | CF transmembrane conductance regulator antagonist | |||
| 0.063 | 0.005 | 0.063 | Carnitine palmitoyltransferase inhibitor | |||
| 0.063 | 0.005 | 0.063 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.062 | 0.005 | 0.062 | Angiotensin AT1 receptor antagonist | |||
| 0.123 | 0.066 | 0.123 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.075 | 0.021 | 0.075 | CC chemokine 2 receptor antagonist | |||
| 0.06 | 0.007 | 0.06 | Prostaglandin EP4 antagonist | |||
| 0.105 | 0.052 | 0.105 | Electrolyte absorption antagonist | |||
| 0.073 | 0.022 | 0.073 | Cannabinoid CB2 receptor antagonist | |||
| 0.138 | 0.088 | 0.138 | Phospholipase A2 inhibitor | |||
| 0.054 | 0.005 | 0.054 | Angiotensin II receptor antagonist | |||
| 0.068 | 0.02 | 0.068 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.09 | 0.042 | 0.09 | CC chemokine receptor antagonist | |||
| 0.075 | 0.028 | 0.075 | MDM2 inhibitor | |||
| 0.136 | 0.09 | 0.136 | Heat shock protein 90 antagonist | |||
| 0.096 | 0.05 | 0.096 | NMDA receptor antagonist | |||
| 0.104 | 0.059 | 0.104 | Chemokine receptor antagonist | |||
| 0.055 | 0.012 | 0.055 | Farnesoid X receptor agonist | |||
| 0.057 | 0.017 | 0.057 | NMDA receptor subunit 3A antagonist | |||
| 0.052 | 0.013 | 0.052 | Purinergic P2X7 antagonist | |||
| 0.043 | 0.005 | 0.043 | Guanylate cyclase 1 stimulant | |||
| 0.088 | 0.051 | 0.088 | Myeloperoxidase inhibitor | |||
| 0.082 | 0.045 | 0.082 | Protein kinase B gamma inhibitor | |||
| 0.163 | 0.128 | 0.163 | Aldehyde oxidase inhibitor | |||
| 0.156 | 0.121 | 0.156 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.048 | 0.014 | 0.048 | Glutamate (mGluR3) antagonist | |||
| 0.051 | 0.017 | 0.051 | Nerve growth factor antagonist | |||
| 0.049 | 0.016 | 0.049 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.23 | 0.197 | 0.571 | Antibacterial | 0.571 0.024 CID_16042756 | CID_16042756 | |
| 0.047 | 0.015 | 0.047 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.104 | 0.073 | 0.104 | Protein kinase (CK2) alpha inhibitor | |||
| 0.07 | 0.039 | 0.07 | Glutamate (mGluR6) antagonist | |||
| 0.043 | 0.012 | 0.043 | Glucagon receptor antagonist | |||
| 0.231 | 0.2 | 0.231 | Transcription factor inhibitor | |||
| 0.038 | 0.009 | 0.038 | NMDA receptor glycine site antagonist | |||
| 0.06 | 0.032 | 0.091 | Aldose reductase inhibitor | 0.091 0.02 CID_16042756 | CID_16042756 | |
| 0.074 | 0.045 | 0.074 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.131 | 0.103 | 0.131 | GABA C receptor rho-2 antagonist | |||
| 0.042 | 0.014 | 0.042 | Glutamate (mGluR8) antagonist | |||
| 0.063 | 0.037 | 0.063 | Potassium channel (Ca-activated) blocker | |||
| 0.213 | 0.188 | 0.213 | Histamine release inhibitor | |||
| 0.076 | 0.052 | 0.076 | GABA aminotransferase inhibitor | |||
| 0.189 | 0.165 | 0.189 | Gastrin inhibitor | |||
| 0.061 | 0.038 | 0.061 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.032 | 0.01 | 0.032 | Prostaglandin D2 antagonist | |||
| 0.077 | 0.055 | 0.077 | Glutamate receptor agonist | |||
| 0.068 | 0.047 | 0.068 | Exportin-1 inhibitor | |||
| 0.089 | 0.068 | 0.089 | ABCA1 expression enhancer | |||
| 0.034 | 0.014 | 0.034 | Carnitine palmitoyltransferase 1A inhibitor | |||
| 0.046 | 0.026 | 0.046 | Guanylate cyclase inhibitor | |||
| 0.109 | 0.09 | 0.124 | Alpha-N-acetylglucosaminidase inhibitor | 0.124 0.074 CID_16042756 | CID_16042756 | |
| 0.096 | 0.077 | 0.292 | Beta glucuronidase inhibitor | 0.292 0.006 CID_16042756 | CID_16042756 | |
| 0.066 | 0.047 | 0.066 | Bcl2 antagonist | |||
| 0.081 | 0.064 | 0.081 | D-Ala-D-Ala ligase inhibitor | |||
| 0.044 | 0.027 | 0.044 | Heme oxygenase inhibitor | |||
| 0.052 | 0.036 | 0.052 | Aconitate hydratase inhibitor | |||
| 0.089 | 0.073 | 0.089 | Protein kinase (CK2) inhibitor | |||
| 0.072 | 0.056 | 0.072 | ErbB-2 antagonist | |||
| 0.035 | 0.02 | 0.035 | Liver X receptor beta agonist | |||
| 0.211 | 0.197 | 0.211 | Calcium channel activator | |||
| 0.042 | 0.028 | 0.042 | Liver X receptor alpha agonist | |||
| 0.059 | 0.044 | 0.059 | Bcl-xL inhibitor | |||
| 0.083 | 0.069 | 0.148 | NADH dehydrogenase inhibitor | 0.148 0.018 CID_16042756 | CID_16042756 | |
| 0.179 | 0.166 | 0.179 | Transcription factor STAT3 inhibitor | |||
| 0.095 | 0.082 | 0.095 | 5 Hydroxytryptamine 3A agonist | |||
| 0.016 | 0.005 | 0.016 | Egl nine homolog 3 inhibitor | |||
| 0.058 | 0.047 | 0.058 | Cannabinoid CB1 receptor antagonist | |||
| 0.166 | 0.157 | 0.166 | Streptokinase A inhibitor | |||
| 0.035 | 0.027 | 0.035 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.043 | 0.035 | 0.095 | Phosphorylase inhibitor | 0.095 0.014 CID_16042756 | CID_16042756 | |
| 0.091 | 0.084 | 0.225 | AMP-activated protein kinase stimulant | 0.225 0.008 CID_16042756 | CID_16042756 | |
| 0.025 | 0.019 | 0.102 | Sodium/glucose cotransporter inhibitor | 0.102 0.003 CID_16042756 | CID_16042756 | |
| 0.062 | 0.056 | 0.062 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.027 | 0.022 | 0.027 | Liver X receptor beta antagonist | |||
| 0.017 | 0.013 | 0.017 | Nicotinic acid receptor 1 antagonist | |||
| 0.028 | 0.024 | 0.028 | Purinergic P2Y14 antagonist | |||
| 0.014 | 0.01 | 0.014 | Angiotensin AT1B receptor antagonist | |||
| 0.052 | 0.049 | 0.052 | Prostaglandin EP2 antagonist | |||
| 0.055 | 0.052 | 0.055 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.014 | 0.011 | 0.014 | Egl nine homolog 1 inhibitor | |||
| 0.025 | 0.022 | 0.025 | Integrin alpha2beta1 antagonist | |||
| 0.086 | 0.084 | 0.086 | GABA C receptor agonist | |||
| 0.034 | 0.031 | 0.034 | Somatostatin 4 agonist | |||
| 0.02 | 0.019 | 0.02 | Angiotensin AT1A receptor antagonist | |||
| 0.072 | 0.071 | 0.079 | Glycine receptor antagonist | 0.079 0.059 CID_16042756 | CID_16042756 | |
| 0.051 | 0.053 | 0.068 | Adenine nucleotide translocase inhibitor | 0.068 0.017 CID_16042756 | CID_16042756 | |
| 0.078 | 0.087 | 0.097 | Thioredoxin inhibitor | 0.097 0.052 CID_16042756 | CID_16042756 | |
| 0.021 | 0.032 | 0.097 | Sodium/glucose cotransporter 2 inhibitor | 0.097 0.003 CID_16042756 | CID_16042756 | |
| 0.108 | 0.126 | 0.12 | Mannose-6-phosphate isomerase inhibitor | 0.12 0.1 CID_16042756 | CID_16042756 | |
| 0.153 | 0.175 | 0.467 | Hypoglycemic | 0.467 0.018 CID_16042756 | CID_16042756 | |
| 0.076 | 0.098 | 0.143 | UDP-glucose 4-epimerase inhibitor | 0.143 0.031 CID_16042756 | CID_16042756 | |
| 0.076 | 0.109 | 0.092 | Glutamate release inhibitor | 0.092 0.056 CID_16042756 | CID_16042756 | |
| 0.115 | 0.151 | 0.139 | CC chemokine 6 receptor antagonist | 0.139 0.042 CID_16042756 | CID_16042756 | |
| 0.107 | 0.147 | 0.194 | Hemostatic | 0.194 0.035 CID_16042756 | CID_16042756 | |
| 0.165 | 0.209 | 0.486 | Transcription factor NF kappa B inhibitor | 0.486 0.046 CID_16042756 | CID_16042756 | |
| 0.066 | 0.112 | 0.081 | Triose-phosphate isomerase inhibitor | 0.081 0.074 CID_16042756 | CID_16042756 | |
| 0.078 | 0.125 | 0.266 | Amylase inhibitor | 0.266 0.024 CID_16042756 | CID_16042756 | |
| 0.034 | 0.086 | 0.075 | Factor IXa inhibitor | 0.075 0.018 CID_16042756 | CID_16042756 | |
| 0.047 | 0.105 | 0.153 | Topoisomerase II alpha inhibitor | 0.153 0.023 CID_16042756 | CID_16042756 | |
| 0.129 | 0.197 | 0.151 | Cyclic AMP phosphodiesterase inhibitor | 0.151 0.15 CID_16042756 | CID_16042756 | |
| 0.08 | 0.149 | 0.186 | Cell adhesion inhibitor | 0.186 0.029 CID_16042756 | CID_16042756 | |
| 0.026 | 0.098 | 0.044 | Neuraminidase (Influenza A) inhibitor | 0.044 0.034 CID_16042756 | CID_16042756 | |
| 0.099 | 0.198 | 0.144 | Interferon gamma antagonist | 0.144 0.087 CID_16042756 | CID_16042756 | |
| 0.143 | 0.248 | 0.476 | Immunomodulator | 0.476 0.027 CID_16042756 | CID_16042756 | |
| 0.068 | 0.182 | 0.143 | Cyclooxygenase 3 inhibitor | 0.143 0.055 CID_16042756 | CID_16042756 | |
| 0.029 | 0.146 | 0.068 | Heparanase inhibitor | 0.068 0.013 CID_16042756 | CID_16042756 | |
| 0.048 | 0.175 | 0.094 | Cell adhesion molecule inhibitor | 0.094 0.039 CID_16042756 | CID_16042756 | |
| 0.091 | 0.229 | 0.194 | Hypolipemic | 0.194 0.099 CID_16042756 | CID_16042756 | |
| 0.143 | 0.29 | 0.422 | Apoptosis antagonist | 0.422 0.033 CID_16042756 | CID_16042756 | |
| 0.025 | 0.19 | 0.059 | Glucose-6-phosphate translocase inhibitor | 0.059 0.025 CID_16042756 | CID_16042756 | |
| 0.023 | 0.203 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.055 CID_16042756 | CID_16042756 | |
| 0.111 | 0.299 | 0.206 | DNA synthesis inhibitor | 0.206 0.114 CID_16042756 | CID_16042756 | |
| 0.05 | 0.239 | 0.201 | Thrombolytic | 0.201 0.051 CID_16042756 | CID_16042756 | |
| 0.037 | 0.235 | 0.137 | Topoisomerase II inhibitor | 0.137 0.056 CID_16042756 | CID_16042756 | |
| 0.076 | 0.28 | 0.253 | Platelet antagonist | 0.253 0.071 CID_16042756 | CID_16042756 | |
| 0.131 | 0.354 | 0.412 | Interleukin 2 agonist | 0.412 0.024 CID_16042756 | CID_16042756 | |
| 0.071 | 0.295 | 0.206 | Insulin secretagoues | 0.206 0.033 CID_16042756 | CID_16042756 | |
| 0.098 | 0.331 | 0.503 | Alpha-glucosidase inhibitor | 0.503 0.08 CID_16042756 | CID_16042756 | |
| 0.065 | 0.336 | 0.126 | DNA repair enzyme inhibitor | 0.126 0.061 CID_16042756 | CID_16042756 | |
| 0.043 | 0.334 | 0.163 | Anticoagulant | 0.163 0.07 CID_16042756 | CID_16042756 | |
| 0.086 | 0.384 | 0.412 | Antithrombotic | 0.412 0.046 CID_16042756 | CID_16042756 | |
| 0.045 | 0.398 | 0.396 | Free radical scavenger | 0.396 0.029 CID_16042756 | CID_16042756 | |
| 0.045 | 0.44 | 0.461 | Antioxidant | 0.461 0.025 CID_16042756 | CID_16042756 | |
| 0.031 | 0.458 | 0.267 | Immunostimulant | 0.267 0.089 CID_16042756 | CID_16042756 | |
| 0.036 | 0.491 | 0.319 | Nitric oxide antagonist | 0.319 0.037 CID_16042756 | CID_16042756 | |
| 0.079 | 0.536 | 0.464 | Apoptosis agonist | 0.464 0.086 CID_16042756 | CID_16042756 | |
| 0.037 | 0.497 | 0.362 | Tumour necrosis factor alpha release inhibitor | 0.362 0.035 CID_16042756 | CID_16042756 | |
| 0.007 | 0.476 | 0.264 | Selectin antagonist | 0.264 0.008 CID_16042756 | CID_16042756 | |
| 0.045 | 0.526 | 0.368 | Immunosuppressant | 0.368 0.077 CID_16042756 | CID_16042756 | |
| 0.037 | 0.581 | 0.326 | Hepatoprotectant | 0.326 0.023 CID_16042756 | CID_16042756 | |
| 0.077 | 0.631 | 0.306 | Peptidyltransferase inhibitor | 0.306 0.022 CID_16042756 | CID_16042756 | |
| 0.011 | 0.578 | 0.122 | Topoisomerase I inhibitor | 0.122 0.054 CID_16042756 | CID_16042756 | |
| 0.027 | 0.608 | 0.407 | Platelet adhesion inhibitor | 0.407 0.011 CID_16042756 | CID_16042756 | |
| 0.019 | 0.633 | 0.251 | Vasodilator | 0.251 0.068 CID_16042756 | CID_16042756 | |
| 0.035 | 0.658 | 0.136 | NOS3 expression enhancer | 0.136 0.088 CID_16042756 | CID_16042756 | |
| 0.043 | 0.711 | 0.218 | Caspase 3 stimulant | 0.218 0.145 CID_16042756 | CID_16042756 | |
| 0.008 | 0.699 | 0.131 | Lipid peroxidase inhibitor | 0.131 0.083 CID_16042756 | CID_16042756 | |
| 0.023 | 0.76 | 0.111 | Transcription factor NF kappa B stimulant | 0.111 0.03 CID_16042756 | CID_16042756 | |
| 0.012 | 0.75 | 0.485 | Angiogenesis stimulant | 0.485 0.013 CID_16042756 | CID_16042756 | |
| 0.008 | 0.765 | 0.054 | Antibiotic Aminoglycoside-like | 0.054 0.011 CID_16042756 | CID_16042756 | |
| 0.003 | 0.764 | 0.072 | Antineoplastic antibiotic | 0.072 0.064 CID_16042756 | CID_16042756 | |
| 0.008 | 0.778 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.024 CID_16042756 | CID_16042756 | |
| 0.006 | 0.78 | 0.067 | Protein 50S ribosomal subunit inhibitor | 0.067 0.026 CID_16042756 | CID_16042756 | |
| 0.003 | 0.865 | 0.021 | Protein 30S ribosomal subunit inhibitor | 0.021 0.02 CID_16042756 | CID_16042756 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |